BioMed Research International

Effects of Microbiota on Cancer Immune Responses and Immunotherapy


Publishing date
01 Sep 2022
Status
Published
Submission deadline
13 May 2022

Lead Editor

1Guangzhou University, Guangzhou, China

2The Research Institute in Oncology and Hematology, Winnipeg, Canada

3McMaster University, Hamilton, Canada

4Universiti Malaysia Sabah, Kota Kinabalu, Malaysia


Effects of Microbiota on Cancer Immune Responses and Immunotherapy

Description

Microbiota collectively refers to all microorganisms living in a defined environment such as on the skin or in the intestinal tract, mouth, vagina, and eyes, including bacteria, archaea, fungi, and viruses. The largest population of microorganisms in the human body locates in the intestine and is called the gut or intestinal microbiota. Intestinal microbes are involved in a variety of physiological functions to maintain the health of the host, including providing nutrients and vitamins, catabolic drugs, and toxins, protecting the body from pathogens, promoting the development of the immune system, and maintaining epithelial mucosal homeostasis. The microbiota plays an important role in the physiology and pathology of the human body.

Cancer is a leading cause of death in the world. According to the World Health Organization (WHO), 10 million people died from cancer in 2020. It is estimated that 10-20% of cancers can be attributed to microbial infections. Many studies have demonstrated that the intestinal microbiota plays an important role in tumorigenesis. Microbes and their products can either have a direct carcinogenic effect or prevent the occurrence and development of cancer by regulating the production of circulating metabolites, inflammation, and immune responses. Cancer immunotherapy is a very promising therapy by boosting the immune system to kill cancer cells and suppress tumor growth. Microbiota on or in the human body can influence immune responses affecting immunotherapy.

This Special Issue invites original research and review articles which contribute to the understanding of the roles of microbiota in cancer immune responses and immunotherapy which may provide novel approaches in treating cancer.

Potential topics include but are not limited to the following:

  • Research and development of microbe-associated cancer immunotherapy
  • Mechanisms of microbiota disturbance in cancer immune responses
  • Correlation of microbiota with tumorigenesis
  • Screening and application of biomarkers of microbiota in cancer immune responses
  • Mechanisms of bacterial translocation causing cancer
  • Relationship between microbiota and mucosal immunity and its anticancer mechanism
  • Signaling pathways of microbiota regulating tumorigenesis
  • Mechanisms and applications of probiotic bacteria in immunotherapy

Articles

  • Special Issue
  • - Volume 2022
  • - Article ID 3858249
  • - Research Article

[Retracted] lncRNA MIR4435-2HG Accelerates the Development of Bladder Cancer through Enhancing IQGAP3 and CDCA5 Expression

Tao Yang | Yan Li | ... | Junjiang Liu
  • Special Issue
  • - Volume 2022
  • - Article ID 5793912
  • - Research Article

[Retracted] LINC00707 Promotes Cell Proliferation in Cervical Cancer via the miR-374c-5p/SDC4 Axis

Fang Fang | Chunfeng Guo | ... | Qingyang Li
  • Special Issue
  • - Volume 2022
  • - Article ID 6918396
  • - Research Article

[Retracted] hsa_circ_0084811 Regulates Cell Proliferation and Apoptosis in Retinoblastoma through miR-18a-5p/miR-18b-5p/E2F5 Axis

Guangwei Jiang | Mingxuan Qu | ... | Shanhao Jiang
  • Special Issue
  • - Volume 2022
  • - Article ID 8282624
  • - Research Article

[Retracted] Study on Inflammatory Factors in Aneurysmal Perimembranous Ventricular Septal Defect in Congenital Heart Disease

Jin Zhou | Ying Liu | ... | Qilian Xie
  • Special Issue
  • - Volume 2022
  • - Article ID 1787854
  • - Research Article

[Retracted] The Treatment Combining Antiangiogenesis with Chemoradiotherapy Impinges on the Peripheral Circulation Vascular Endothelial Cells and Therapeutic Effect in the Patients with Locally Advanced Nasopharyngeal Carcinoma

Xiuyun Gong | Limin Wang | ... | Feng Jin
  • Special Issue
  • - Volume 2022
  • - Article ID 2309339
  • - Research Article

[Retracted] Prokineticins as a Prognostic Biomarker for Low-Grade Gliomas: A Study Based on The Cancer Genome Atlas Data

Junqing Zhong | Ding Xiang | Xinlong Ma
  • Special Issue
  • - Volume 2022
  • - Article ID 3546795
  • - Research Article

[Retracted] LINC00518 Promotes Cell Malignant Behaviors via Influencing EIF4A3-Mediated mRNA Stability of MITF in Melanoma

Ping Zhang | Xuefeng Liu | ... | Wenliang Lv
  • Special Issue
  • - Volume 2022
  • - Article ID 5312897
  • - Research Article

[Retracted] Mechanism of Sevoflurane Anesthesia under Hypothermic Cardiopulmonary Bypass on Postoperative Atrial Fibrillation Rhythm in Patients Undergoing Mitral Valve Replacement

Hao Che | Yufang Lv | ... | Liyun Zhao
  • Special Issue
  • - Volume 2022
  • - Article ID 4085039
  • - Research Article

[Retracted] The Expression Profile of miRNA in Glioma and the Role of miR-339-5p in Glioma

Jie Lin | Shouyi Wang | ... | Buyi Zheng
  • Special Issue
  • - Volume 2022
  • - Article ID 3092063
  • - Research Article

[Retracted] Silencing of Long Noncoding RNA HLA Complex P5 (HCP5) Suppresses Glioma Progression through the HCP5-miR-205-Vascular Endothelial Growth Factor A Feedback Loop

Rui Cheng | Lei Ji | ... | Hongming Ji
BioMed Research International
 Journal metrics
See full report
Acceptance rate8%
Submission to final decision128 days
Acceptance to publication21 days
CiteScore5.300
Journal Citation Indicator-
Impact Factor-
 Submit Evaluate your manuscript with the free Manuscript Language Checker

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.